PT  - JOURNAL ARTICLE
AU  - Fang, Yitian
AU  - You, Li
AU  - Kimenai, Hendrikus J.A.N.
AU  - Chien, Miao-Ping
AU  - Dor, Frank J.M.F.
AU  - de Bruin, Ron W.F.
AU  - Minnee, Robert C.
TI  - Machine Learning-Driven Assessment of Early Graft Function in Living Donor Kidney Transplantation Using Intraoperative Laser Speckle Contrast Imaging
AID  - 10.1101/2025.10.07.25336974
DP  - 2025 Jan 01
TA  - medRxiv
PG  - 2025.10.07.25336974
4099  - http://medrxiv.org/content/early/2025/10/08/2025.10.07.25336974.short
4100  - http://medrxiv.org/content/early/2025/10/08/2025.10.07.25336974.full
AB  - Background Although living donor kidney transplantation (LDKT) generally achieves excellent outcomes, 5–12% of recipients experience early graft dysfunction, which is associated with poorer long-term survival. Current predictive tools rely mainly on clinical parameters and lack intraoperative applicability. Laser speckle contrast imaging (LSCI) enables real-time, non-contact assessment of renal microcirculation, and may provide complementary insight when integrated with machine learning (ML).Methods In this prospective cohort study, we performed intraoperative LSCI measurement in 110 adult LDKT recipients at Erasmus Medical Center. Early graft function was assessed by estimated glomerular filtration rate (eGFR) at 1 week posttransplant, with patients classified as Group I (eGFR ≥ 30 mL/min/1.73 m²) and Group II (eGFR < 30 mL/min/1.73 m²). Two predefined feature sets were used for model development: (i) a Clinical Model (selected clinical variables) and (ii) a Combined Model (clinical + convolutional neural network [CNN]-derived LSCI features). Four ML algorithms (support vector machine [SVM], logistic regression, random forest [RF], and XGBoost) were trained using 5-fold cross-validation with Synthetic Minority Oversampling Technique (SMOTE) and evaluated on independent test sets across 30 repeated iterations.Results Of 110 recipients, 15 (17%) had eGFR < 30 mL/min/1.73 m² at 1 week. Patients in Group II received kidneys from older donors with lower predonation eGFR, had higher BMI, more cardiovascular comorbidity, and greater intraoperative blood loss. The Combined Model consistently outperformed the Clinical Model across all algorithms. For example, SVM achieved higher accuracy (0.89 [95% CI, 0.85–0.92] vs. 0.79 [0.75–0.84]) and logistic regression yielded higher recall (0.86 [0.83–0.88] vs. 0.76 [0.74–0.79]). In independent test sets, Combined Models maintained better performance, with SVM achieving the highest F1 score (0.60 [0.50–0.71]) and RF achieving the highest recall (0.88 [0.50–1.00]). Grad-CAM visualizations confirmed that CNN-extracted features localized to physiologically relevant perfusion regions. LSCI also enabled real-time detection and correction of vascular complications in two cases.Conclusions Integrating intraoperative LSCI features with clinical variables using ML significantly improved prediction of low one-week eGFR (< 30 mL/min/1.73m²) in LDKT compared with clinical data alone. LSCI also enabled real-time detection of vascular complications, underscoring its role as both a predictive and intraoperative guidance tool. Larger multicenter studies are warranted to validate its generalizability and explore applications in other transplant scenarios.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics committee of Erasmus MC waived ethical approval for this workI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors